The 2021 HTRS Mid-Career Research Award (MCRA) is complete. Recipient details below.
Watch for an announcement to come regarding the 2022 HTRS MCRA program. In the meantime, please see the 2021 Request for Proposals (RFP) for general eligiblity requirements and submission guidelines. Questions should be directed to Jennifer Ziegler in the HTRS office at [email protected].
The HTRS Mid-Career Research Award (MCRA) Program provides financial support for mid-career investigators pursuing clinical, translational, or basic science research projects in hemostasis and/or thrombosis. Applicants must be working in the United States or Canada for the duration of the proposed project. Projects funded by this program run for two years.
The goals of the MCRA Program are to:
Eligible investigators must be:
For more info, CLICK HERE
Evan M. Braunstein, MD, PhD - Johns Hopkins University
The 2021 MCRA was supported by a grant from HTRS.
Bryce A. Kerlin, MD - The Research Institute at Nationwide Children's Hospital
The 2020 MCRA was supported by a grant from Genentech, a member of the Roche Group.
Jill M. Johnsen, MD - Bloodworks Northwest Research Institute
The 2019 MCRA was supported by an educational grant from Genentech.
Shannon L. Meeks, MD - Emory University
The 2017 MCRA was supported by the Hemostasis and Thrombosis Research Society.